Physician-Pharmacist Collaboration Maintains Adherence To Buprenorphine Treatment

People with opioid use disorder (OUD) being treated with buprenorphine whose treatment was managed by a pharmacist had high rates of adherence to treatment. About 89% of consumers who transferred to receive medication management from the pharmacist stayed in treatment. About 5% of those being monitored by a pharmacist had opioid-positive urine drug screens (UDS) at one or more of the six UDS conducted while under pharmacist supervision. About 90% of those who were transferred to pharmacist supervision said holding the visit at the same place the medication is dispensed was very or extremely useful/convenient. Pharmacists used the . . .